TABLE 3.
Prevalence of MDR among P. aeruginosa strains in various parts of the world
| Region | Period | Setting | Resistance (%) | Reference |
|---|---|---|---|---|
| North America | ||||
| United States | 2001 | ICU/non-ICU | 9.1/7.0 | 35 |
| United States | 2002 | ICU | 14 | 35 |
| United States | 2003 | Nosocomial infections | 9.9 | 36 |
| South America, 10 sites | 1997-1999 | Nosocomial infections | 8.2 | 24 |
| Europe | ||||
| 12 to 23 sites | 1997-1999 | Nosocomial infections | 4.7 | 24 |
| 33 ICUs | 1997-2000 | ICU | 3-50 | 29 |
| Asia/Pacific | ||||
| 17 sites | 1997-1999 | Nosocomial infections | 1.6 | 24 |
| Japan | 2001 | Nosocomial infections | 2.8 | 74 |
| Malaysia | 2005 | Nosocomial infections | 6.9 | 62 |